Healthcare Costs of Stroke and Major Bleeding in Patients With Atrial Fibrillation Treated With Non–vitamin K Antagonist Oral Anticoagulants

Journal of Medical Economics - United Kingdom
doi 10.1080/13696998.2019.1603156